Choate Investment Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $728K | Buy |
10,415
+12
| +0.1% | +$839 | 0.02% | 234 |
|
|
2025
Q1 | $765K | Buy |
10,403
+530
| +5% | +$39K | 0.02% | 215 |
|
|
2024
Q4 | $647K | Buy |
9,873
+4,053
| +70% | +$266K | 0.02% | 240 |
|
|
2024
Q3 | $453K | Buy |
5,820
+557
| +11% | +$43.4K | 0.01% | 271 |
|
|
2024
Q2 | $410K | Sell |
5,263
-100
| -2% | -$7.8K | 0.01% | 274 |
|
|
2024
Q1 | $363K | Buy |
5,363
+2,000
| +59% | +$136K | 0.01% | 307 |
|
|
2023
Q4 | $226K | Sell |
3,363
-328
| -9% | -$22.1K | 0.01% | 349 |
|
|
2023
Q3 | $250K | Buy |
3,691
+864
| +31% | +$58.5K | 0.01% | 316 |
|
|
2023
Q2 | $202K | Buy |
+2,827
| New | +$202K | 0.01% | 282 |
|